TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis
Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gr...
Saved in:
Published in | International journal of cardiology Vol. 371; pp. 299 - 304 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
15.01.2023
|
Subjects | |
Online Access | Get full text |
ISSN | 0167-5273 1874-1754 1874-1754 |
DOI | 10.1016/j.ijcard.2022.10.143 |
Cover
Loading…
Abstract | Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes.
2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients.
Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01).
NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration.
•Normal-flow low-gradient aortic stenosis (NFLG-AS) is a common subset.•Guidelines give no conclusive recommendations for patients with NFLG-AS.•Patients with NFLG-AS are a heterogeneous cohort; dPmean can discriminate subsets.•NFLG-AS patients with higher dPmean resemble high-gradient AS patients.•NFLG-AS patients with lower dPmean have an increased mortality after TAVI. |
---|---|
AbstractList | Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes.BACKGROUNDNormal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes.2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients.METHODS2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients.Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01).RESULTSCharacteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01).NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration.CONCLUSIONSNFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration. Normal-flow (stroke volume index, SVi >35 ml/m ) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes. 2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients. Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01). NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration. Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to give conclusive treatment recommendations. We hypothesized that NFLG patients are heterogenous, containing a subgroup similar to high-gradient aortic stenosis patients (dPmean ≥40 mmHg, HG-AS) concerning characteristics and outcomes. 2326 patients undergoing transcatheter aortic valve replacement (TAVI) at our centre between 2013 and 2019 were analysed. 386 patients fulfilled criteria of NFLG-AS. Their median dPmean was 33 mmHg, which was used for grouping (204 patients with higher gradient NFLG-AS, 186 patients with lower gradient NFLG-AS). They were compared to 956 HG-AS patients. Characteristics of lower gradient NFLG-AS patients differed from HG-AS patients in many aspects while higher gradient NFLG-AS and HG-AS patients were mostly similar, underscored by higher Society of Thoracic Surgeons scores in lower gradient NFLG-AS (lower gradient NFLG-AS, 3.9, HG-AS, 3.0, p = 0.03, higher gradient NFLG-AS, 3.0, p = 0.04). Procedural complications were comparable. Estimated 3-year all-cause mortality was higher in lower gradient NFLG-AS compared to HG-AS patients (hazard ratio 1.7, p < 0.01), whereas mortality of higher gradient NFLG-AS was similar to HG-AS patients (hazard ratio 1.2, p = 0.31). Cardiovascular mortality was highest among lower gradient NFLG-AS patients (21.6% vs. higher gradient NFLG-AS, 15.4%, vs. HG-AS, 11.1%, p < 0.01). NFLG-AS patients are indeed heterogenous. NFLG-AS patients with higher gradients resemble HG-AS patients in clinical characteristics and outcomes and should not be treated differently. Lower gradient NFLG-AS patients have increased long-term mortality and the use of TAVI requires careful consideration. •Normal-flow low-gradient aortic stenosis (NFLG-AS) is a common subset.•Guidelines give no conclusive recommendations for patients with NFLG-AS.•Patients with NFLG-AS are a heterogeneous cohort; dPmean can discriminate subsets.•NFLG-AS patients with higher dPmean resemble high-gradient AS patients.•NFLG-AS patients with lower dPmean have an increased mortality after TAVI. |
Author | Andreae, David Orban, Martin Steffen, Julius Theiss, Hans Deseive, Simon Peterß, Sven Haum, Magda Rizas, Konstantinos Braun, Daniel Reißig, Nikolas Hausleiter, Jörg Doldi, Philipp M. Nabauer, Michael Massberg, Steffen |
Author_xml | – sequence: 1 givenname: Julius surname: Steffen fullname: Steffen, Julius organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 2 givenname: David surname: Andreae fullname: Andreae, David organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 3 givenname: Michael surname: Nabauer fullname: Nabauer, Michael organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 4 givenname: Nikolas surname: Reißig fullname: Reißig, Nikolas organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 5 givenname: Philipp M. surname: Doldi fullname: Doldi, Philipp M. organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 6 givenname: Magda surname: Haum fullname: Haum, Magda organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 7 givenname: Martin surname: Orban fullname: Orban, Martin organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 8 givenname: Hans surname: Theiss fullname: Theiss, Hans organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 9 givenname: Konstantinos surname: Rizas fullname: Rizas, Konstantinos organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 10 givenname: Daniel surname: Braun fullname: Braun, Daniel organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 11 givenname: Sven surname: Peterß fullname: Peterß, Sven organization: Herzchirurgische Klinik und Poliklinik, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 12 givenname: Jörg surname: Hausleiter fullname: Hausleiter, Jörg organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 13 givenname: Steffen surname: Massberg fullname: Massberg, Steffen organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany – sequence: 14 givenname: Simon surname: Deseive fullname: Deseive, Simon email: simon.deseive@med.uni-muenchen.de organization: Medizinische Klinik und Poliklinik I, Klinikum der Universität München, LMU München, Marchioninistr. 15, 81377 Munich, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36306951$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkMtKAzEUhoMoWi9vIJKlm6nJ5NKOiFDES6HgRgVXIU3O2NSZSU1Sxbc3tYrgposQOOf7fzjfPtrufAcIHVPSp4TKs3nfzY0Otl-SsuyvppxtoR4dDnhBB4Jvo17GBoUoB2wP7cc4J4Twqhruoj0mGZGVoD30_DB6GuPaB7zQyUGXIv5waYY7H1rdFHXjP3B-xUvQdrXGxrcLHcDi5PHMvcz-NtqH5AyOCTofXTxEO7VuIhz9_Afo8eb64equmNzfjq9Gk8IwLlKhuZAlmFJrPpWWVawmltNSSAKUSDul9bBmdcWH0gKVlBBJBUgtBJXMAtPsAJ2uexfBvy0hJtW6aKBpdAd-GVU-n7AMizKjJz_octqCVYvgWh0-1a-ODJyvARN8jAFqZVzKXnyXgnaNokSt3Ku5WrtXK_ffU85ymP8L__ZviF2uY5AlvTsIKprs04B1AUxS1rtNBRf_CkzjOmd08wqfm-NfCVezlA |
CitedBy_id | crossref_primary_10_1007_s00392_023_02245_w crossref_primary_10_1016_j_carrev_2024_06_014 |
Cites_doi | 10.1093/ehjci/jez191 10.1038/bmt.2009.359 10.1093/eurheartj/ehw096 10.1016/j.jacc.2013.08.1621 10.1093/eurheartj/eht094 10.1016/j.jcin.2019.01.233 10.1161/CIRCULATIONAHA.112.001094 10.1007/s00392-022-02011-4 10.1093/eurheartj/ehaa799 10.1093/eurheartj/ehab395 10.1093/ehjci/jew335 10.1016/j.jcmg.2015.09.026 10.1161/JAHA.119.012301 10.1016/j.jacc.2020.02.046 10.1093/ehjci/jez211 10.1136/hrt.2003.030601 10.1161/CIRCULATIONAHA.112.001290 |
ContentType | Journal Article |
Copyright | 2022 Elsevier B.V. Copyright © 2022 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2022 Elsevier B.V. – notice: Copyright © 2022 Elsevier B.V. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.ijcard.2022.10.143 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1874-1754 |
EndPage | 304 |
ExternalDocumentID | 36306951 10_1016_j_ijcard_2022_10_143 S0167527322016552 |
Genre | Comment Journal Article |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO ABBQC ABFNM ABJNI ABLJU ABMAC ABMZM ABOCM ACDAQ ACGFS ACIEU ACIUM ACRLP ACVFH ADBBV ADCNI ADEZE AEBSH AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFPUW AFRHN AFTJW AFXIZ AGCQF AGUBO AGYEJ AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFKBS EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM M29 M41 MO0 N9A O-L O9- OA. OAUVE OL~ OZT P-8 P-9 P2P PC. Q38 ROL RPZ SAE SCC SDF SDG SEL SES SPCBC SSH SSZ T5K UV1 Z5R ~G- 0SF AACTN AFCTW AFKWA AHHHB AJOXV AMFUW .55 .GJ 29J AAQXK AAYWO AAYXX ABWVN ABXDB ACRPL ADMUD ADNMO ADVLN AFFNX AGHFR AGQPQ AGRNS ASPBG AVWKF AZFZN CITATION EJD FEDTE FGOYB G-2 HEB HMK HMO HVGLF HZ~ R2- RIG SEW WUQ X7M ZGI CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c345t-a4562ec2aa4b6d393f0d412560e106db1f8f3f9486de16100615e6a55163de3a3 |
IEDL.DBID | .~1 |
ISSN | 0167-5273 1874-1754 |
IngestDate | Mon Jul 21 09:33:45 EDT 2025 Thu Apr 03 07:02:37 EDT 2025 Thu Apr 24 23:12:35 EDT 2025 Tue Jul 01 04:04:34 EDT 2025 Tue Dec 03 03:44:46 EST 2024 Tue Aug 26 16:54:35 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Aortic stenosis VARC-3 Low-flow low-gradient Normal-flow low-gradient TAVI |
Language | English |
License | Copyright © 2022 Elsevier B.V. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c345t-a4562ec2aa4b6d393f0d412560e106db1f8f3f9486de16100615e6a55163de3a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Commentary-3 content type line 23 |
PMID | 36306951 |
PQID | 2730316352 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_2730316352 pubmed_primary_36306951 crossref_citationtrail_10_1016_j_ijcard_2022_10_143 crossref_primary_10_1016_j_ijcard_2022_10_143 elsevier_sciencedirect_doi_10_1016_j_ijcard_2022_10_143 elsevier_clinicalkey_doi_10_1016_j_ijcard_2022_10_143 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2023-01-15 |
PublicationDateYYYYMMDD | 2023-01-15 |
PublicationDate_xml | – month: 01 year: 2023 text: 2023-01-15 day: 15 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | International journal of cardiology |
PublicationTitleAlternate | Int J Cardiol |
PublicationYear | 2023 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Salaun, Clavel, Hahn (bb0025) 2020 Chadha, Bohbot, Rusinaru, Marechaux, Tribouilloy (bb0075) 2019; 8 Vahanian, Beyersdorf, Praz (bb0005) 2022; 43 Berthelot-Richer, Pibarot, Capoulade (bb0085) 2016; 9 Namasivayam, He, Churchill (bb0095) 2020; 75 Mehrotra, Jansen, Flynn (bb0050) 2013; 34 Généreux, Piazza, Alu (bb0060) 2021; 42 Herrmann, Pibarot, Hueter (bb0100) 2013; 127 Clavel, Magne, Pibarot (bb0035) 2016; 37 Guzzetti, Pibarot, Clavel (bb0040) 2019; 20 Fischer-Rasokat, Renker, Liebetrau (bb0030) 2019; 12 Otto, Nishimura, Bonow (bb0010) 2021; 143 Steffen, Reissig, Andreae (bb0020) 2022 Clavel, Messika-Zeitoun, Pibarot (bb0080) 2013; 62 Baumgartner, Hung, Bermejo (bb0015) 2017; 18 Ozkan, Hachamovitch, Kapadia, Tuzcu, Marwick (bb0045) 2013; 128 Scrucca, Santucci, Aversa (bb0065) 2010; 45 Saeed, Vamvakidou, Seifert, Khattar, Li, Senior (bb0070) 2019; 20 Kadem, Dumesnil, Rieu, Durand, Garcia, Pibarot (bb0090) 2005; 91 Vahanian (10.1016/j.ijcard.2022.10.143_bb0005) 2022; 43 Baumgartner (10.1016/j.ijcard.2022.10.143_bb0015) 2017; 18 Namasivayam (10.1016/j.ijcard.2022.10.143_bb0095) 2020; 75 Steffen (10.1016/j.ijcard.2022.10.143_bb0020) 2022 Généreux (10.1016/j.ijcard.2022.10.143_bb0060) 2021; 42 Berthelot-Richer (10.1016/j.ijcard.2022.10.143_bb0085) 2016; 9 Fischer-Rasokat (10.1016/j.ijcard.2022.10.143_bb0030) 2019; 12 Otto (10.1016/j.ijcard.2022.10.143_bb0010) 2021; 143 Salaun (10.1016/j.ijcard.2022.10.143_bb0025) 2020 Herrmann (10.1016/j.ijcard.2022.10.143_bb0100) 2013; 127 Mehrotra (10.1016/j.ijcard.2022.10.143_bb0050) 2013; 34 Chadha (10.1016/j.ijcard.2022.10.143_bb0075) 2019; 8 Guzzetti (10.1016/j.ijcard.2022.10.143_bb0040) 2019; 20 Kadem (10.1016/j.ijcard.2022.10.143_bb0090) 2005; 91 Ozkan (10.1016/j.ijcard.2022.10.143_bb0045) 2013; 128 Clavel (10.1016/j.ijcard.2022.10.143_bb0080) 2013; 62 Clavel (10.1016/j.ijcard.2022.10.143_bb0035) 2016; 37 Saeed (10.1016/j.ijcard.2022.10.143_bb0070) 2019; 20 Scrucca (10.1016/j.ijcard.2022.10.143_bb0065) 2010; 45 27190103 - Eur Heart J. 2016 Sep 07;37(34):2645-57 |
References_xml | – volume: 9 start-page: 797 year: 2016 end-page: 805 ident: bb0085 article-title: Discordant grading of aortic stenosis severity publication-title: JACC Cardiovasc. Imaging – start-page: 13 year: 2020 ident: bb0025 article-title: Outcome of flow-gradient patterns of aortic stenosis after aortic valve replacement publication-title: Circulation – volume: 127 start-page: 2316 year: 2013 end-page: 2326 ident: bb0100 article-title: Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis publication-title: Circulation – volume: 45 start-page: 1388 year: 2010 end-page: 1395 ident: bb0065 article-title: Regression modeling of competing risk using R: an in depth guide for clinicians publication-title: Bone Marrow Transplant. – volume: 128 start-page: 622 year: 2013 end-page: 631 ident: bb0045 article-title: Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction publication-title: Circulation – volume: 20 start-page: 1094 year: 2019 end-page: 1101 ident: bb0070 article-title: The impact of aortic valve replacement on survival in patients with normal flow low gradient severe aortic stenosis: a propensity-matched comparison publication-title: Eur. Heart J. Cardiovasc. Imaging – volume: 12 start-page: 752 year: 2019 end-page: 763 ident: bb0030 article-title: 1-year survival after TAVR of patients with low-flow, low-gradient and high-gradient aortic valve stenosis in matched study populations publication-title: JACC Cardiovasc. Interv. – volume: 20 start-page: 1102 year: 2019 end-page: 1104 ident: bb0040 article-title: Normal-flow low-gradient severe aortic stenosis is a frequent and real entity publication-title: Eur. Heart J. Cardiovasc. Imaging – volume: 43 start-page: 561 year: 2022 end-page: 632 ident: bb0005 article-title: 2021 ESC/EACTS guidelines for the management of valvular heart disease publication-title: Eur. Heart J. – volume: 143 start-page: e72 year: 2021 end-page: e227 ident: bb0010 article-title: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines publication-title: Circulation – volume: 8 year: 2019 ident: bb0075 article-title: Outcome of normal-flow low-gradient severe aortic stenosis with preserved left ventricular ejection fraction: a propensity-matched study publication-title: J. Am. Heart Assoc. – year: 2022 ident: bb0020 article-title: TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes publication-title: Clin. Res. Cardiol. – volume: 91 start-page: 354 year: 2005 end-page: 361 ident: bb0090 article-title: Impact of systemic hypertension on the assessment of aortic stenosis publication-title: Heart – volume: 34 start-page: 1906 year: 2013 end-page: 1914 ident: bb0050 article-title: Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis publication-title: Eur. Heart J. – volume: 42 start-page: 1825 year: 2021 end-page: 1857 ident: bb0060 article-title: Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research publication-title: Eur. Heart J. – volume: 18 start-page: 254 year: 2017 end-page: 275 ident: bb0015 article-title: Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography publication-title: Eur. Heart J. Cardiovasc. Imaging – volume: 75 start-page: 1758 year: 2020 end-page: 1769 ident: bb0095 article-title: Transvalvular flow rate determines prognostic value of aortic valve area in aortic stenosis publication-title: J. Am. Coll. Cardiol. – volume: 37 start-page: 2645 year: 2016 end-page: 2657 ident: bb0035 article-title: Low-gradient aortic stenosis publication-title: Eur. Heart J. – volume: 62 start-page: 2329 year: 2013 end-page: 2338 ident: bb0080 article-title: The complex nature of discordant severe calcified aortic valve disease grading publication-title: J. Am. Coll. Cardiol. – volume: 20 start-page: 1094 year: 2019 ident: 10.1016/j.ijcard.2022.10.143_bb0070 article-title: The impact of aortic valve replacement on survival in patients with normal flow low gradient severe aortic stenosis: a propensity-matched comparison publication-title: Eur. Heart J. Cardiovasc. Imaging doi: 10.1093/ehjci/jez191 – volume: 45 start-page: 1388 year: 2010 ident: 10.1016/j.ijcard.2022.10.143_bb0065 article-title: Regression modeling of competing risk using R: an in depth guide for clinicians publication-title: Bone Marrow Transplant. doi: 10.1038/bmt.2009.359 – volume: 37 start-page: 2645 year: 2016 ident: 10.1016/j.ijcard.2022.10.143_bb0035 article-title: Low-gradient aortic stenosis publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehw096 – start-page: 13 year: 2020 ident: 10.1016/j.ijcard.2022.10.143_bb0025 article-title: Outcome of flow-gradient patterns of aortic stenosis after aortic valve replacement publication-title: Circulation – volume: 62 start-page: 2329 year: 2013 ident: 10.1016/j.ijcard.2022.10.143_bb0080 article-title: The complex nature of discordant severe calcified aortic valve disease grading publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2013.08.1621 – volume: 34 start-page: 1906 year: 2013 ident: 10.1016/j.ijcard.2022.10.143_bb0050 article-title: Differential left ventricular remodelling and longitudinal function distinguishes low flow from normal-flow preserved ejection fraction low-gradient severe aortic stenosis publication-title: Eur. Heart J. doi: 10.1093/eurheartj/eht094 – volume: 12 start-page: 752 year: 2019 ident: 10.1016/j.ijcard.2022.10.143_bb0030 article-title: 1-year survival after TAVR of patients with low-flow, low-gradient and high-gradient aortic valve stenosis in matched study populations publication-title: JACC Cardiovasc. Interv. doi: 10.1016/j.jcin.2019.01.233 – volume: 128 start-page: 622 year: 2013 ident: 10.1016/j.ijcard.2022.10.143_bb0045 article-title: Impact of aortic valve replacement on outcome of symptomatic patients with severe aortic stenosis with low gradient and preserved left ventricular ejection fraction publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.001094 – year: 2022 ident: 10.1016/j.ijcard.2022.10.143_bb0020 article-title: TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes publication-title: Clin. Res. Cardiol. doi: 10.1007/s00392-022-02011-4 – volume: 42 start-page: 1825 year: 2021 ident: 10.1016/j.ijcard.2022.10.143_bb0060 article-title: Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehaa799 – volume: 43 start-page: 561 year: 2022 ident: 10.1016/j.ijcard.2022.10.143_bb0005 article-title: 2021 ESC/EACTS guidelines for the management of valvular heart disease publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehab395 – volume: 18 start-page: 254 year: 2017 ident: 10.1016/j.ijcard.2022.10.143_bb0015 article-title: Recommendations on the echocardiographic assessment of aortic valve stenosis: a focused update from the European Association of Cardiovascular Imaging and the American Society of Echocardiography publication-title: Eur. Heart J. Cardiovasc. Imaging doi: 10.1093/ehjci/jew335 – volume: 9 start-page: 797 year: 2016 ident: 10.1016/j.ijcard.2022.10.143_bb0085 article-title: Discordant grading of aortic stenosis severity publication-title: JACC Cardiovasc. Imaging doi: 10.1016/j.jcmg.2015.09.026 – volume: 143 start-page: e72 year: 2021 ident: 10.1016/j.ijcard.2022.10.143_bb0010 article-title: 2020 ACC/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association joint committee on clinical practice guidelines publication-title: Circulation – volume: 8 year: 2019 ident: 10.1016/j.ijcard.2022.10.143_bb0075 article-title: Outcome of normal-flow low-gradient severe aortic stenosis with preserved left ventricular ejection fraction: a propensity-matched study publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.119.012301 – volume: 75 start-page: 1758 year: 2020 ident: 10.1016/j.ijcard.2022.10.143_bb0095 article-title: Transvalvular flow rate determines prognostic value of aortic valve area in aortic stenosis publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2020.02.046 – volume: 20 start-page: 1102 year: 2019 ident: 10.1016/j.ijcard.2022.10.143_bb0040 article-title: Normal-flow low-gradient severe aortic stenosis is a frequent and real entity publication-title: Eur. Heart J. Cardiovasc. Imaging doi: 10.1093/ehjci/jez211 – volume: 91 start-page: 354 year: 2005 ident: 10.1016/j.ijcard.2022.10.143_bb0090 article-title: Impact of systemic hypertension on the assessment of aortic stenosis publication-title: Heart doi: 10.1136/hrt.2003.030601 – volume: 127 start-page: 2316 year: 2013 ident: 10.1016/j.ijcard.2022.10.143_bb0100 article-title: Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.112.001290 – reference: 27190103 - Eur Heart J. 2016 Sep 07;37(34):2645-57 |
SSID | ssj0004998 |
Score | 2.3968887 |
Snippet | Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to... Normal-flow (stroke volume index, SVi >35 ml/m ) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to... Normal-flow (stroke volume index, SVi >35 ml/m2) low-gradient (dPmean <40 mmHg) aortic stenosis (NFLG-AS) is subject of scientific debate. Guidelines fail to... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 299 |
SubjectTerms | Aortic stenosis Aortic Valve - surgery Aortic Valve Stenosis - diagnostic imaging Aortic Valve Stenosis - surgery Humans Low-flow low-gradient Normal-flow low-gradient Severity of Illness Index Stroke Volume TAVI Transcatheter Aortic Valve Replacement - adverse effects Treatment Outcome VARC-3 Ventricular Function, Left |
Title | TAVI for patients with normal-flow low-gradient compared to high-gradient aortic stenosis |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0167527322016552 https://dx.doi.org/10.1016/j.ijcard.2022.10.143 https://www.ncbi.nlm.nih.gov/pubmed/36306951 https://www.proquest.com/docview/2730316352 |
Volume | 371 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDI4mkBAXxJvxmILEtXskadceJ8Q0QNuFDY1TlTQJGppaRIu48dux22aIwwTi0IsbK63jOJ8T2yHkSsueimwEM41JBQ5Kv-tJK7XHrApFCGuCNpjgPJ4Eo5m4m_vzBrl2uTAYVlnb_sqml9a6pnRqaXZeF4vOAwbQY_kwxjAlx0c7LEQftbz9-R3mAYg-dPW9sbVLnytjvBYvCYwDeImMtZEq-LrlaR38LJeh4S7ZqfEjHVSfuEcaJt0nW-P6hPyAPE0Hj7cUkCitK6bmFLdaaYrYdOnZZfZB4fGe38pYr4K6IHRaZBRrF3-_kRl2QkEN0ixf5IdkNryZXo-8-voEL-HCLzyJzo1JmJRCBZpH3Ha16CHEMeAHatWzoeU2EmGgDeC-EtyYQOLJGdeGS35ENtIsNSeEIkgxhikVBUxYziMAYV0lVMi0r1WQNAl3UouTurY4XnGxjF0Q2UtcyTpGWZdUwZvEW3G9VrU1fmnvuwGJXd4oWLoYjP8vfP0V3w_d-gPnpRv3GKYdnqXI1GTveQyaBOYQ0BprkuNKIVb_wAPwwwC5nv673zOyjdfa41ZPzz8nG8Xbu7kA8FOoVqndLbI5uL0fTb4AuCACxw |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwEB6hVtrlstoXbFkWvNJeQ1vbSZNjhUAt0F62IDhZdmyviqoE0aD9-8wkThEHBOKQi5OR4_F4_I09D4A_Vg9N5jNcaVwbNFBGg0h7bSPuTSpT3BOsowDn2TyZXMqz6_h6C47bWBhyqwy6v9HptbYOLf3Azf7dctn_Sw70lD6McwrJiVEPdyk7VdyB7nh6Ppk_hUdmdUncOsU3EbQRdLWb1_I2x6lAQ5HzI2qV4qUd6iUEWu9Ep5_hU4CQbNz85RfYcsVX-DALl-Tf4GYxvpoyBKMsJE1dMzptZQXB01XkV-V_hk_0775296pY64fOqpJR-uKnN7qkThhKQlGul-vvcHl6sjieRKGCQpQLGVeRJvvG5VxraRIrMuEHVg4J5Tg0Ba0Z-tQLn8k0sQ6hX41vXKLp8kxYJ7TYgU5RFu4HMMIpznFjsoRLL0SGOGxgpEm5ja1J8h6IlmsqD-nFqcrFSrV-ZLeq4bUiXtetUvQg2lDdNek1Xvk-bidEtaGjqOwU6v9X6EYbumfi9QbK3-28K1x5dJ2iC1c-rBVKEmpEBGy8B7uNQGzGIBI0xRC87r2730P4OFnMLtTFdH7-E7apyj2d_AzjfehU9w_uF2KhyhwEWX8Ek3sFeA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=TAVI+for+patients+with+normal-flow+low-gradient+compared+to+high-gradient+aortic+stenosis&rft.jtitle=International+journal+of+cardiology&rft.au=Steffen%2C+Julius&rft.au=Andreae%2C+David&rft.au=Nabauer%2C+Michael&rft.au=Rei%C3%9Fig%2C+Nikolas&rft.date=2023-01-15&rft.issn=0167-5273&rft.volume=371&rft.spage=299&rft.epage=304&rft_id=info:doi/10.1016%2Fj.ijcard.2022.10.143&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_ijcard_2022_10_143 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-5273&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-5273&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-5273&client=summon |